Polycythemia Support - Myeloproliferative Disorder Polycythemia Support - Myeloproliferative Disorder

Polycythemia Support

2/23/06
Primary polycythemia ("vera") 
Primary polycythemia, often called polycythemia vera (PCV), polycythemia rubra vera (PRV), erythremia, or just PV, occurs when excess erythrocytes are produced as a result of tumorous abnormalities of the bone marrow. Often, excess white blood cells ( leukocytosis) and platelets 
( thrombocytosis) are also produced. It is, therefore, classified as a myeloproliferative disease (MPD). 
 
Secondary polycythemia 

Secondary polycythemia  is caused by either appropriate or inappropriate increases in the production of erythropoietin that result in an increased production of erythrocytes. In secondary polycythemia their may be 6 to 8 million and occasionally 9 million erythrocytes per cubic millimeter of blood. A type of secondary polycythemia in which the production of erythropoietin increases appropriately is called physiologic polycythemia. Physiologic polycythemia occurs in individuals living at high altitudes (4275 to 5200 meters), where oxygen availability is less than 
at sea level. Such people may have 6 to 8 million erythrocytes per cubic millimeter of blood. 
 
Other causes of secondary polycythemia include smoking, renal or liver tumors, or heart faults that result in hypoxia. Hypoxia has several meanings: Hypoxia is the lack of oxygen in tissues, see Hypoxia (medical) Hypoxia is the lack of oxygen in a water body leading to the death of organisms. 
 
Relative polycythemia 

Relative polycythemia is an apparent raise of the erythrocyte level in the blood; however, the underlying cause is reduced plasma blood. Relative polycythemia is often caused by low fluid intake or stress. 

~~~~~~~~~~~~~~~~~

Diagnosis and Causes - Written so YOU can read and understand it!
"The Views of a Patient" (Thank You Nelson!!)
Red Cell Mass Test (
measures the level of red cells relative to body mass.)
The red blood cell mass (true vs. spurious polycythemia) is becoming difficult to obtain because the chromium Cr 51 isotope needed to perform the test is no longer readily available.
 
A Red Cell Mass test uses a nuclear medicine procedure to dope a sample of blood, re-circulate it and then assess the mass of red cells relative to body mass. Not a very invasive procedure just requiring a small port to be put into an arm artery or vein (the same one they take blood test samples from and kept there for the hour or two that the procedure takes and then removed. Most of the time taken is waiting time! The RCM is a conclusive indicator. The BMB will give some answers but may not give a conclusive diagnosis of PRV.
 
Links about Red Call Mass Test

Should whole-body red cell mass be measured or calculated?
Analysis of red cell mass and plasma volume in patients with polycythemia.

~~~~~~~~

Green and Black Tea Studies

~~~~~~~~~

Dana-Farber Cancer Institute Harvard Chronic Myeloproliferative Disorder (MPD) Study
 
What is the Harvard MPD Study 
The Harvard MPD Study is an observational study of people who have one of the chronic myeloproliferative disorders (MPDs); essential thrombocytosis (ET), polycythemia vera (PV) or agnogenic myeloid metaplasia with myelofibrosis (AMM/MF). The purpose of this study is to learn more about MPDs and its treatment by studying people in the United States. Investigators affiliated with the Harvard MPD Study will use the information you provide (along with the blood samples and mouth swabs provided by some people) to conduct research. This research study has been approved and will be monitored by the Institutional Review Board (IRB) of the Dana-Farber Cancer Institute, Boston, MA.
 
How do I participate in the study?

If you are interested in participating in the study, please supply the following information by phone, toll-free at 866-428-3265, or by email to mwadleigh@partners.org

I have _______ ET

            _______ PV
            _______ AMM

Also, please indicate your interest in the different aspects of the study:

_________ I am interested in completing the survey.
_________ I am willing to sign a release of medical records for research purposes.
_________ I am interested in donating a blood sample and mouth swab for research Purposes.

 
Name:___________________________________________
Address:_________________________________________
City, State, ZIP____________________________________

Dr. Wadleigh or her assistant will mail you more information about the study, as well as a consent form and the survey. 

      
Researchers Discover Cause of Several Incurable Bone Marrow Malignancies   

Dana-Farber Cancer Institute
Harvard Chronic MPD Study

MPD (Myeloproliferative Disorders) Foundation
      
In support of NIH and NCI Funding of Myeloproliferative Disorder Research 

MPD Gene Discovery!!
 MPD Patient Survey
Spring 2005 Newsletter
 MPD Patient Brochure

Friends of ET

Online Support Groups
* Yahoo Groups -PV Support
* Myeloproliferative Disease Support Group
* The Myeloproliferative Disorders Support Group
* MSN - Blood Diseases Support Community

When you join a support group online it is good netiquette to introduce yourself and include some of the following information ... 
Are you Male or Female? Age?
How long have you had polycythemia vera?
How were you diagnosed? Test performed?
What treatments have you received? (IE: Phlebotomy, Hydrea (HU), Aspirin, Anagrelide (Agrylin), P32, Interferon)
What symptoms of the disease are You having? (IE: increase in spleen size, gout, need for phlebotomy, anemia, headache, itching)
Any other questions, concerns or comments you wish to add!

                            
                    
Polycythemia Links 
*
Polycythemia Vera Website
* The MPD-SUPPORT-L Webpage
*
National Cancer Institute
* National Center for Biotechnology Information - U.S. National Library of Medicine
* Blood Online
* MPD Foundation
* Friends of ET Research

* NORD - National Organization for Rare Disorders, Inc.
* CancerCell.org

Primary polycythemia (PV)
* Polycythemia vera myths, mechanisms, and 
management - Dr. Jerry Spivak 
* Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin.  
* EMedicine

Secondary & Relative
* EMedicine
* Secondary polycythemia

 

The Leukemia & Lymphoma Society

NMDP Home

The National Organization for Rare Disorders (NORD)
National Organization for Rare Disorders, Inc.

http://www.hopkinskimmelcancercenter.org

 

ACRONYMS

ABMT autologous bmt (your own marrow)
AG Agrylin (Anagrelide)
ALL acute lymphocytic leukemia
AML acute myelocytic leukemia
AMM agnogenic myeloid metaplasia; (also called primary myelofibrosis)
BANDS band neutrophils
BASOS basophils
BMT bone marrow transplant
CBC complete blood count
CML chronic myelogenous leukemia
EECs endogenous erythroid colonies
EOS eosinophils
EPO erythropoeitin
ET essential thrombocythemia
GM-CSF granulocyte/monocyte colony stimulating factor
HCT hematocrit (normal range = Male: 45 - 62% / Female: 37 - 48%)
HGB hemoglobin (normal range = Male: 13 - 18 gm/dL / Female: 12 - 16 gm/dL) 
HU Hydrea (Hydroxyurea)
IGF-1 insulin-like growth factor-1
IGFBP-1 insulin-like growth factor binding protein-1
INF Interferon
LYMPHS      lymphocytes
MCH mean corpuscular hemoglobin  (normal range = 27 - 32 pg/cell)
MCHC mean corpuscular hemoglobin concentration (normal range = 32 - 36% hemoglobin/cell) 
MCV mean corpuscular value (normal range = 76 - 100 cu µm)
MDS myelodysplastic syndrome
MF myelofibrosis
MONOS monocytes
MM myeloid metaplasia
MMM myeloid metaplasia w/myelofibrosis
MPD myeloproliferative disorders
MUD matched unrelated donor
P-32 radioactive phosphorus
PBPC peripheral blood progenitor cell transplant
PBSCT peripheral blood stem cell transplant
PHLEB phlebotomy - taking off some blood
PLT platelets (normal range = 150,000 - 350,000/mL)
PRN as needed
PSCT as in PBSCT but "blood" omitted
PV Polycythemia
PRV Polycythemia Rubra Vera
RBC red blood cell count (normal range = 4.2 - 6.9 million/µL/cu mm ) 
RCM red cell mass test
SCF stem cell factor
SEGS segmented neutrophils
SBMT syngeneic bmt (marrow from an identical twin)
STAT signal transducer and activator of transcription
WBC white blood cells (normal range = 4,300 - 10,800 cells/µL/cu mm) 

  Join us at Yahoo Groups -PV Support

This page is compiled by a patient that has had PV for over10 years, you can contact Sue at semh@earthlink.net